World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
22732
World Ranking
15719
National Ranking
76

Ben Davidson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ben Davidson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 431 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ben Davidson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ben Davidson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ben Davidson is affiliated with Oslo University Hospital in Norway and has a significant body of work primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research spans critical subfields including Obstetrics and Gynecology, Reproductive Medicine, Molecular Biology, Surgery, and Oncology.

The scientist's main research topics include:

  • Ovarian cancer diagnosis and treatment
  • Endometrial and Cervical Cancer Treatments
  • Intraperitoneal and Appendiceal Malignancies
  • Cancer Genomics and Diagnostics
  • Sarcoma Diagnosis and Treatment
  • Uterine Myomas and Treatments
  • Occupational and environmental lung diseases

They have contributed extensively to several prominent publication venues, such as:

  • Gynecologic Oncology (13 publications)
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (12 publications)
  • International Journal of Gynecological Cancer (6 publications)
  • Cytopathology (5 publications)
  • Cancer Research (3 publications)

Ben Davidson's frequent co-authors include:

  • Arild Holth, with 16 shared publications
  • Ane Gerda Zahl Eriksson, with 12 shared publications
  • Kristina Lindemann, with 11 shared publications
  • Emmet McCormack, with 8 shared publications
  • Kjersti Flatmark, with 8 shared publications

Among their recent published papers are:

  • ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease, 2024, Annals of Oncology
  • Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers, 2020, Cancer Research
  • Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers, 2022, Nature Communications
  • TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol, 2023, International Journal of Gynecological Cancer
  • CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model, 2020, EBioMedicine

Best Publications

  • ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

    N. Colombo;C. Sessa;A. du Bois;J. Ledermann

  • Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance

    Jean Pierre Gillet;Anna Maria Calcagno;Sudhir Varma;Miguel Marino

  • Snail, Slug, and Smad‐interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma

    Sivan Elloul;Mari Bukholt Elstrand;Jahn M. Nesland M.D.;Claes G. Tropé M.D.

  • MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer

    Neetu Dahiya;Cheryl A. Sherman-Baust;Tian-Li Wang;Ben Davidson

  • Notch3 gene amplification in ovarian cancer.

    Joon T. Park;Mei Li;Kentaro Nakayama;Tsui Lien Mao

  • Transcriptional Gene Silencing Promotes DNA Hypermethylation through a Sequential Change in Chromatin Modifications in Cancer Cells

    Clare Stirzaker;Jenny Z. Song;Ben Davidson;Susan J. Clark

  • Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

    Tuan Zea Tan;Qing Hao Miow;Ruby Yun Ju Huang;Meng Kang Wong

  • High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma.

    Ben Davidson;Iris Goldberg;Walter H. Gotlieb;Juri Kopolovic

  • Notch3 Overexpression Is Related to the Recurrence of Ovarian Cancer and Confers Resistance to Carboplatin

    Joon Tae Park;Xu Chen;Claes G. Tropè;Claes G. Tropè;Ben Davidson

  • Laminin-induced signaling in tumor cells

    Vered Givant-Horwitz;Ben Davidson;Reuven Reich

  • Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)

    W. Glenn McCluggage;Meagan J. Judge;Blaise A. Clarke;Ben Davidson

  • The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells.

    Ben Davidson;Soren Nielsen;Jette Christensen;Pia Asschenfeldt

  • NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma.

    Hiep Phuc Dong;Mari Bunkholt Elstrand;Arild Holth;Ilvars Silins

  • Laminin-Induced Signaling in Tumor Cells: The Role of the Mr 67,000 Laminin Receptor

    Vered Givant-Horwitz;Ben Davidson;Reuven Reich

  • High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations

    Rajmohan Murali;Ben Davidson;Oluwole Fadare;Joseph A. Carlson

  • Epithelial-mesenchymal transition in ovarian carcinoma.

    Ben Davidson;Claes Göran Trope;Reuven Reich

  • EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.

    Ben Davidson;Iris Goldberg;Aasmund Berner;Gunnar B. Kristensen

  • Apolipoprotein E Is Required for Cell Proliferation and Survival in Ovarian Cancer

    Yu Chi Chen;Gudrun Pohl;Tian Li Wang;Patrice J. Morin

  • Nuclear factor κB transcription factors are coexpressed and convey a poor outcome in ovarian cancer

    Christina M. Annunziata;Helene Tuft Stavnes;Lilach Kleinberg;Aasmund Berner

  • HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer

    Andrew E. Teschendorff;Andrew E. Teschendorff;Shih Han Lee;Shih Han Lee;Allison Jones;Heidi Fiegl

Frequent Co-Authors

Claes G. Tropé
Claes G. Tropé University of Oslo
Jahn M. Nesland
Jahn M. Nesland Oslo University Hospital
Ie Ming Shih
Ie Ming Shih Johns Hopkins University
Sverre Heim
Sverre Heim Oslo University Hospital
Tian Li Wang
Tian Li Wang Johns Hopkins University
Gunnar B. Kristensen
Gunnar B. Kristensen Oslo University Hospital
Ioannis Panagopoulos
Ioannis Panagopoulos Oslo University Hospital
Iris Goldberg
Iris Goldberg Sheba Medical Center
Elise C. Kohn
Elise C. Kohn National Institutes of Health
Philip Lazarovici
Philip Lazarovici Hebrew University of Jerusalem

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Choosing to study Medicine in the USA opens doors to many alternative and complementary healthcare careers. If you’re seeking flexible study options, a variety of pharmacy school online programs now offer accredited paths to earning advanced pharmacy degrees from home. These programs can lead to dynamic roles in community, clinical, or research pharmacy.

For those interested in healthcare data and administration, pursuing an him degree online is a smart move. Health Information Management professionals are in high demand and work with medical records, patient privacy, and informatics.

Students who want to enter the healthcare industry quickly may consider medical billing and coding classes online. These programs can be completed in a short time frame, equipping you with essential skills to start a career in medical billing, coding, and insurance claims management.

Another high-demand pathway is nursing. With the rise of telemedicine and remote care, affordable np programs make it possible to become a nurse practitioner and provide advanced patient care, often with flexible online coursework.

Best Scientists Citing Ben Davidson

Trending Scientists

Recently Published Articles